CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...
Phase 2
Valencia, Spain and 72 other locations
in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-low breast cancer with active brain metastases.This study will ana...
Phase 2
Valencia, Valencia, Spain and 12 other locations
Breast cancer (BC) is the most commonly diagnosed cancer in women worldwide, with early-onset cases increasing due to gene...
Valencia, Spain and 6 other locations
-positive / HER2-negative breast cancer which has spread beyond the original tumor and/or to other organs.During this study, anti-h...
Phase 3
Valencia, Spain and 53 other locations
This program initially aims to recruit 1300 breast cancer patients from a large number of hospitals across Europe. Eligible patient...
Valencia, Spain and 52 other locations
A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...
Phase 1
Valencia, Spain and 16 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Valencia, Spain and 107 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Valencia, Spain and 319 other locations
Immune checkpoint inhibitors given in monotherapy in advanced breast cancer have shown modest benefit in first-line, but very limit...
Phase 2
Valencia, Spain and 14 other locations
growth factor receptor 2 negative (ER+/HER2-) advanced/metastatic breast cancer. The phase 1b part of the trial will determine the ...
Phase 1, Phase 2
Valencia, Spain and 85 other locations
Clinical trials
Research sites
Resources
Legal